ExcepGen

Producer of complex human proteins intended to offer an innovative platform to transform drug discovery. The company's proteins are produced through proprietary technology from human cells inactive, full-length form with high yield, and no workarounds.

Overview Structured Data Issues Contributors

Is a

Company attributes

Industry

0

0

Biopharmaceutical

Location

0

0

B2X

0

CEO

Thomas Folliard

0

Founder

Barbara Mertins

0

Thomas Folliard

0

Pitchbook URL

pitchbook.com/profiles...268560-28

Accelerator

0

Accelerator Batch

Y Combinator W19 Batch

0

Number of Employees (Ranges)

1 – 100

Email Address

info@excepgen.com0

info@excepgen.com?subject=ExcepGen%20Inquiry

Number of Employees

100

Full Address

780 Bryant St. San Francisco CA 941070

Investors

0

0

Founded Date

2017

0

Total Funding Amount (USD)

9,150,000

Latest Funding Round Date

July 1, 2020

Board of Directors

Thomas Folliard

0

Latest Funding Type

Country

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

9,000,000

Public/Private

Private0

Y Combinator URL

ycombinator.com/compani...excepgen0

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like ExcepGen

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.